首页 | 本学科首页   官方微博 | 高级检索  
     


Deferiprone in Friedreich ataxia: A 6‐Month randomized controlled trial
Authors:Massimo Pandolfo MD  Javier Arpa MD  Martin B. Delatycki PhD  Kim Hanh Le Quan Sang PhD  Caterina Mariotti MD  Arnold Munnich MD  PhD  Irene Sanz‐Gallego MD  Geneieve Tai BBiomedSC  Mark A. Tarnopolsky MD  PhD   FRCP  Franco Taroni MD  Michael Spino PharmD  Fernando Tricta MD
Affiliation:1. Department of Neurology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium;2. Neurology Service, La Paz University Hospital, Madrid, Spain;3. Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia;4. Necker–Sick Children Hospital Center, Paris, France;5. Unit of Genetics of Neurodegenerative and Metabolic Disease, Carlo Besta Neurological Institute, Institute of Hospitalization and Scientific Care Foundation, Milan, Italy;6. Division of Neurology, Department of Medicine, McMaster University Medical Centre, Hamilton, Ontario, Canada;7. ApoPharma, Toronto, Ontario, Canada
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号